CSTS -VAP Prevention Data Collection Instructions

31
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 CSTS -VAP Prevention Data Collection Instructions Presented by Sean Berenholtz MD, MHS, FCCM June 13, 2012 Armstrong Institute for Patient Safety and Quality

description

CSTS -VAP Prevention Data Collection Instructions. Presented by Sean Berenholtz MD, MHS , FCCM June 13, 2012 Armstrong Institute for Patient Safety and Quality. Objectives . To introduce the VAP Prevention Bundle To go over the instructions for VAP Daily Rounding Form. - PowerPoint PPT Presentation

Transcript of CSTS -VAP Prevention Data Collection Instructions

Page 1: CSTS -VAP Prevention  Data Collection Instructions

© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011

CSTS -VAP Prevention Data Collection InstructionsPresented by Sean Berenholtz MD, MHS, FCCM June 13, 2012

Armstrong Institute for Patient Safety and Quality

Page 2: CSTS -VAP Prevention  Data Collection Instructions

Objectives

• To introduce the VAP Prevention Bundle • To go over the instructions for VAP Daily

Rounding Form

Armstrong Institute for Patient Safety and Quality2

Page 3: CSTS -VAP Prevention  Data Collection Instructions

VAP Daily Rounding Form

Armstrong Institute for Patient Safety and Quality3

Page 4: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality4

Basic Information

• Hospital: Enter the number for your hospital.

• Unit ID#: Enter the number of your ICU unit.

• Date: Enter today’s date as MM/DD/YYYY format (e.g. 06/01/2011).

Page 5: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality5

For All Bed’s

Bed #: Enter all the bed numbers on the form, whether the patient is on mechanical ventilation or not. Include empty beds.

Intub/Trach & Mech Vent: Is the patient currently receiving mechanical ventilation?

• Enter ‘Y’ if the patient is intubated/trached and mechanically ventilated.

• Enter ‘N’ if the patient is not intubated /trached and mechanically ventilated.

Mechanical ventilation is defined as receiving ventilator support via an ETT or tracheostomy tube. Patients treated with non-invasive ventilation would be counted as ‘N’

Page 6: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality6

Date of Intubation

Enter the date that the patient was intubated

•MM/DD/YYYY format (e.g. 06/01/2012)

•DO NOT use dates from re-intubation following self-extubation.

•If the patient is re-intubated following <24 hours after extubation, use first intubation date.

Page 7: CSTS -VAP Prevention  Data Collection Instructions

Time of Shift

Armstrong Institute for Patient Safety and Quality7

Enter the shift during which the data was collected.

• Enter ‘AM’ if completed between 12 midnight and 12 noon.

• Enter ‘PM’ if completed between 12 noon and 12 midnight.

Page 8: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality8

Sub-G ETT Question

Does the patient have a subglottic suctioning endotracheal tube ( Sub- G ETT)?

– Enter ‘Y’ if the patient has a Sub-G ETT.

– Enter ‘N’ if the patient does not have a Sub-G ETT.

– Enter ‘C’ if the use of a Sub-G ETT is contraindicated.

Page 9: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality9

Sub-G ETT Contraindication Question

What is the contraindication for the use of a Sub-G ETT?

– Enter ‘0’ - Other

– Enter ‘1’ – Tracheostomy

Page 10: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality10

Sub-G ETT Functionality Question

Does Sub-G ETT Work? Is the subglottic tube functional?

– Enter ‘Y’ if the patient has a functioning Sub-G ETT

– Enter ‘N’ if the patient Sub-G ETT is not functioning.

– Enter ‘N/A’ if the patient does not have Sub-G ETT

Page 11: CSTS -VAP Prevention  Data Collection Instructions

Head of Bed Question

Armstrong Institute for Patient Safety and Quality11

Is the head of the bed (HOB) at or over thirty degrees from the horizontal?

– Enter ‘Y’ if the HOB is at ≥30 degrees .

– Enter ‘N’ if the HOB not at ≥30 degrees.

– Enter ‘C’ if HOB at ≥30 degrees is contraindicated.

Page 12: CSTS -VAP Prevention  Data Collection Instructions

Head of Bed Contraindications

Armstrong Institute for Patient Safety and Quality12

What is the contraindication to placing the head of the bed at an angle of more than or equal to 30 degrees when compared to a horizontal surface?

– Enter ‘0’ - Other – Enter ‘1’ - Hypotension– Enter ‘2’ - Unstable Physiological Status– Enter ‘3’ - Low Cardiac Index – Enter ‘4’ - Cervical, thoracic or lumbar surgery or instability – Enter ‘5’ - LVAD– Enter ‘6’ – RVAD– Enter ‘7’- Intra aortic balloon pump– Enter ‘8’ – Open abdomen

Page 13: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality13

Oral Care Question

How many times has the patient had oral care without CHG in the last 24 hours? (Q4)

– Enter ‘0’ if Oral Care has not been performed.– Enter ‘1’ if Oral Care has been performed once. – Enter ‘2’ if Oral Care has been performed twice .– Enter ‘3’ if Oral Care has been performed three times.– Enter ‘4’ if Oral Care has been performed four times or

more.– Enter ‘C’ if the use of Oral Care is contraindicated.

Page 14: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality14

Oral Care Definitions

Oral Care without CHG includes ALL the following four interventions. 1. Perform subglottic suctioning2. Ensure proper ETT cuff inflation3. Clean oral cavity with suction swab using 1.5% hydrogen

peroxide based solution4. Moisturize mucosa with swab

Page 15: CSTS -VAP Prevention  Data Collection Instructions

Oral Care Contraindication

Armstrong Institute for Patient Safety and Quality15

What is the contraindication for oral care?

– Enter ‘0’ - Other

Page 16: CSTS -VAP Prevention  Data Collection Instructions

Oral Care with Chlorhexidine –Question

• How many times in the last 24 hours has the patient had Oral Care with CHG? (Q12)

– Enter ‘0’ if Oral Care with CHG has not been performed. – Enter ‘1’ if Oral Care with CHG has been performed once.– Enter ‘2’ if Oral Care with CHG has been performed twice or

more. – Enter ‘C’ if Oral Care with CHG is contraindicated.

Armstrong Institute for Patient Safety and Quality16

Haddis Tujuba
Does this mean that if Orcal Care is Contraindicated then were going to count CHG Oral Care Contraindicated ?If so does that mean that counts twice against the Unite?
Page 17: CSTS -VAP Prevention  Data Collection Instructions

Oral Care with Chlorhexadine –Definition

Oral Care with CHG includes ALL the following four interventions; 1. Perform oral care as in “oral care without CHG”2. Chlorhexidine

a. Use alcohol free CHGb. 10cc – squirt 5cc on right side of mouth between cheek

and gum, being sure to get upper and lower teeth, front to back, pharynx and tongue

c. Swab with toothette if needed to reach tongue/gumsd. Suction out pools in mouthe. Repeat on left side with remaining 5ccf. If patient requires nystatin, give CHG and nystatin 6

hours apartg. Or, use your manufacturers directions for use

Armstrong Institute for Patient Safety and Quality17

Page 18: CSTS -VAP Prevention  Data Collection Instructions

Oral Care with Chlorhexidine –Contraindications

• What is the contraindication for the use of CHG in the oral care regimen?

– Enter ‘0’ –Other

– Enter ‘1’ If the patient is known to have an allergic or hypersensitivity reaction to chlorhexidine

– Enter ‘2’ if the patient is < 2 months of age.

– Enter ‘3’ if the patient might come in direct contact with CHG through the meninges.

– Enter ‘4’ if all oral care is contraindicated. Armstrong Institute for Patient Safety and Quality

18

Page 19: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality19

Page 20: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Awakening Trials Question

20

Has the patient had a Spontaneous Awakening Trial (SAT) in the last 24 hours?

Page 21: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Awakening Screen and Trial

Armstrong Institute for Patient Safety and Quality21

Page 22: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Awakening Trial Contraindication

22

What is the contraindication for this patient having a Spontaneous Awakening Trial?

– Enter ‘0’ –Other

– Enter ‘1’ if the patient is receiving a sedative infusion for active seizures or alcohol withdrawal.

– Enter ‘2’ if the patient is receiving neuromuscular blockers.

– Enter ‘3’ if the patient has had evidence of active myocardial ischemia in the previous 24 h.

– Enter ‘4’ if patient has evidence of increased intracranial pressure .

Page 23: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Breathing Trial Question

23

Has this patient had a Spontaneous Breathing Trial (SBT) within the last 24 hours? – Enter ‘Y’ if the patient has had a SBT within the previous

24 hours.– Enter ‘N’ if the patient has not had a SBT within the

previous 24 hours.– Enter ‘C’ if the use of a SBT is contraindicated and

documented in the medical record.

Page 24: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Breathing Screen

24

SBT Safety Screen: – Patients pass the screen if:

• They have passed the SAT trial or are responsive to verbal stimuli

• They have adequate oxygenation (SpO2>=88% or an F2O2 of <=50% and a PEEP <=cm H2O)

• They have any spontaneous inspiratory effort within a 5-min period

• There is an abrupt change in mental status• There is currently no significant use of vasopressors or

inotropes• There is no evidence of increased intracranial pressure

Page 25: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Breathing Trial

25

• SBT Trial:• Ventilatory support is removed• Patient breathes through T-tube circuit of ventilator circuit

with CPAP of 5cm H2O or pressure support of < 7cm H2O.• Patients pass if they don’t develop failure criteria for >= 120

minutes.– Respiratory rate of > 35 or < 8 breaths per minute or

longer– Hypoxemia (SpOs < 88% for >=5 min)– Abrupt change in mental status– An acute cardiac arrhythmia– Two or more signs of respiratorydistress

» Tachycardia» Bradycardia» Use of accessory muscles» Abdominal paradox» Diaphoresis» Marked dyspnea

Page 26: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Breathing Trial Contraindication

26

What is the contraindication for this patient having a Spontaneous Breathing Trial?

– Enter ‘0’ –Other – Enter ‘1’ if the patient is receiving a sedative

infusion for active seizures or alcohol withdrawal.– Enter ‘2’ if the patient is receiving

neuromuscular blockers.– Enter ‘3’ if the patient has had evidence of active

myocardial ischemia in the previous 24 h. – Enter ‘4’ if patient has evidence of increased

intracranial pressure .

Page 27: CSTS -VAP Prevention  Data Collection Instructions

Spontaneous Breathing Trial Contraindication

27

What is the contraindication for this patient having a Spontaneous Breathing Trial?– Enter ‘0’ –Other – Enter ‘1’ if the patient didn’t pass the SAT safety

screen.– Enter ‘2’ if the patient did not meet adequate

oxygenation [SpO2 < 88% on an F1O2 of <= 50%and a PEEP of <=3 cm H2O .

– Enter ‘3’ if the patient did not meet criteria of no spontaneous inspiratory effort in a 5-min period

– Enter ‘4’ if patient has acute agitation requiring escalating sedative doses.

– Enter ‘5’ if patient has significant use of vasopressors or inotropes.

– Enter ‘6’ if patient has increased intracranial pressure

Page 28: CSTS -VAP Prevention  Data Collection Instructions

Armstrong Institute for Patient Safety and Quality28

Page 29: CSTS -VAP Prevention  Data Collection Instructions

Reports

• % Compliance for each Process Measure

• Comparison Reports with other CSTS Site’s

• VAP Rates over Time

Armstrong Institute for Patient Safety and Quality29

Page 30: CSTS -VAP Prevention  Data Collection Instructions

Next Steps

• Start Data Collection – Time – We are ready when you are.– Limit Number of Data Collectors to Improve

Accuracy of Data Collection

• Send Scanned Copies– Email : [email protected] – Fax :

Armstrong Institute for Patient Safety and Quality30

Page 31: CSTS -VAP Prevention  Data Collection Instructions

Questions ?

Armstrong Institute for Patient Safety and Quality31